COSOPT - Dorzolamide HCL - Timolol Maleate

Cosopt Used For

Cosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers & failed to achieve target IOP determined after multiple measurements over time.

Directions for Cosopt

The recommended dosage is one drop of Cosopt in the affected eye(s) two times daily. If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart.

How Cosopt works

Cosopt should not be administered to patients with severe renal impairment since the active ingredients are predominantly excreted by the kidney. Certain patients might develop local ocular adverse effects, primarily conjunctivitis and lid reactions due to chronic administration of this medication. These reactions might disappear upon discontinuation of drug therapy. Patients with bronchial asthma, a history of bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second or third degree atrioventricular block, or cardiac failure should not be prescribed Cosopt. For patients with diminished myocardial contractility, Cosopt may lead to greater risk of myocardial infarction and is not advisable for use.

Side effects of Cosopt

Like all other medicines, Cosopt also has its own side effects which include taste perversion (bitter, sour, or unusual taste), conjunctival hyperemia, blurred vision, superficial punctate keratitis or eye itching, abdominal pain, back pain, blepharitis, bronchitis, corneal erosion, corneal staining, cortical lens opacity, cough, dizziness, dryness of eyes, dyspepsia, eye debris, eye discharge, eye pain, eye tearing, eyelid edema, eyelid erythema, eyelid exudate/scales, eyelid pain or discomfort, foreign body sensation, glaucomatous cupping, headache, hypertension, influenza, pharyngitis, post-subcapsular cataract, sinusitis, upper respiratory infection, urinary tract infection, visual field defect, fatigue, arrhythmia, cerebral ischemia, worsening of angina pectoris, palpitation, cardiac arrest, pulmonary edema, somnolence, insomnia, nightmares, behavioral changes and psychic disturbances including confusion, hallucinations, anxiety, disorientation, nervousness, and memory loss. It is advisable to get regular medical evaluation conducted while on therapy with this medication.

Other Cosopt Information

The tip of the dispensing container should not come in contact with the eye or surrounding structures since this could contaminate the solution and cause serious damage to the eye.